Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: A review of the literature from the past decade

Postgraduate Medicine

Volumn 125, Issue 2, 2013, Pages 40-50

  Nellesen, Dave ^a   Chawla, Anita ^a   Oh, Debora L ^b   Weissman, Tar Yn ^c   Lavins, B J ^d   Murray, Christopher W ^d  

^a ANALYSIS GROUP   (United States)

^b Forest Research Institute ^*

^c FOREST RESEARCH INSTITUTE   (United States)

^d IRONWOOD PHARMACEUTICALS INC   (United States)

Author keywords

Chronic constipation; Comorbidities; Disease burden; Irritable bowel syndrome

Indexed keywords

ALLERGY; ARTICLE; CHRONIC DISEASE; CHRONIC IDIOPATHIC CONSTIPATION; COMORBIDITY; CONSTIPATION; DEPRESSION; DIABETES MELLITUS; DYSPEPSIA; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOPATHOLOGY; IRRITABLE COLON; MENTAL DISEASE; PREVALENCE; UROGENITAL TRACT DISEASE;

COMORBIDITY; CONSTIPATION; HUMANS; IRRITABLE BOWEL SYNDROME; PREVALENCE; WORLD HEALTH;

EID: 84876765501     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2013.03.2640     Document Type: Article

References (73)

1. Locke GR 3rd, Pemberton JH, Phillips SF. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology. 2000;119(6):1761-1766.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mea-rin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-1491.
3. Halpert AD. Importance of early diagnosis in patients with irritable bowel syndrome. Postgrad Med. 2010;122(2):102-111.
4. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-1390.
5. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(suppl 1):S1-S4.
6. Hoch R, Schoenfeld P. Symptom frequency, healthcare seeking behavior, and satisfaction with therapy among chronic constipation patients with both constipation and abdominal symptoms: results of a population-based survey. Poster presented at: American Academy of Nurse Practitioners Annual Meeting; June 22-26, 2011; Las Vegas, NV.
7. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol. 2005;100(5):1174-1184.
8. Almquist E, Guyonnet D, Tornblom H, Van Oudenhove L, Tack JF, Simren M. Characterization of bowel habit in IBS patients using the Bristol Stool Form Scale. Poster presented at: Digestive Disease Week 2012; May 19-22, 2012; San Diego, CA. Poster 1371.
9. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22(10):935-942.
10. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21(11): 1365-1375.
11. Stelwagon M, Chey WD, Olden KW. Symptom frequency, healthcare seeking behavior and satisfaction with therapy among IBS-C patients meeting Rome II criteria: results of a population-based survey. Poster presented at: American Academy of Nurse Practitioners Annual Meeting; June 22-26, 2011; Las Vegas, NV
12. Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs. 2003;5(1):56-65.
13. Herman J, Pokkunuri V, Braham L, Pimentel M. Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. Gend Med. 2010;7(3):240-246.
14. Nam SY, Kim BC, Ryu KH, Park BJ. Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests. J Neurogastroenterol Motil. 2010;16(1): 47-51.
15. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11(4):265-269.
16. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(suppl 1): S5-S21.
17. Graham DP, Savas L, White D, et al. Irritable bowel syndrome symptoms and health related quality of life in female veterans. Aliment Pharmacol Ther. 2010;31(2):261-273.
18. Park JM, Choi MG, Kim YS, et al. Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res. 2009;18(4):435-446.
19. Thijssen AY, Jonkers DM, Leue C, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44(10):e236-e241.
20. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23(5):461-476.
21. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97(8): 1986-1993.
22. Mitra D, Davis KL, Baran RW. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome. Postgrad Med. 2011;123(3):122-132.
23. Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005;7(4):264-271.
24. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17(1):29-34.
25. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol. 2009;7(1):9-19.
26. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122(4):1140-1156.
27. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
28. Department of Health and Human Services; Centers for Medicaid and Medicare Services. Evaluation and Management Services Guide. Baltimore, MD: Department of Health and Human Services; 2010.
29. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32(11):637-641.
30. Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol. 1993;28(5):427-432.
31. Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160(18):2808-2816.
32. Zhao YF, Ma XQ, Wang R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther. 2011;34(8): 1020-1029.
33. Grover M, Kanazawa M, Palsson OS, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil. 2008;20(9):998-1008.
34. Mann NS, Limoges-Gonzales M. The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome. Hepatogastroenterology. 2009;56(91-92):718-721.
35. Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol. 2010;10:23.
36. Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol. 2011;26(suppl 3):135-138.
37. Barbezat G, Poulton R, Milne B, Howell S, Fawcett JP, Talley N. Prevalence and correlates of irritable bowel symptoms in a New Zealand birth cohort. N Z Med J. 2002;115(1164):U220.
38. Bommelaer G, Dorval E, Denis P, et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol. 2002;26(12):1118-1123.
39. Ferrazzi S, Thompson GW, Irvine EJ, Pare P, Rance L. Diagnosis of constipation in family practice. Can J Gastroenterol. 2002;16(3): 159-164.
40. Jurcić D, Bilić A, Schwarz D, et al. Lower gastrointestinal disorders in patients with irritable bowel syndrome. Coll Antropol. 2008;32(3): 755-759.
41. Bilić A, Jurcić D, Schwarz D, et al. Impaired esophageal function in patients with irritable bowel syndrome. Coll Antropol. 2008;32(3): 747-753.
42. Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008; 27(1):22-28.
43. Si JM, Wang LJ, Chen SJ, Sun LM, Dai N. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004; 10(7):1059-1064.
44. Sorouri M, Pourhoseingholi MA, Vahedi M, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol. 2010;16(3):154-160.
45. Lacerda-Filho A, Lima MJ, Magalhães MF, Paiva RA, Cunha-Melo JR. Chronic constipation-the role of clinical assessment and colorectal physiologic tests to obtain an etiologic diagnosis. Arq Gastroenterol. 2008;45(1):50-57.
46. Mearin F, Badía X, Balboa A, et al; RITMO Group. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Aliment Pharmacol Ther. 2006;23(6): 815-826.
47. Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol. 2006;12(48):7844-7847.
48. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003; 98(5):1107-1111.
49. Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, et al. Obesity and functional constipation; a community-based study in Iran. J Gastro intestin Liver Dis. 2009;18(2):151-155.
50. Sun SX, Dibonaventura M, Purayidathil FW, Wagner JS, Dabbous O, Mody R. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci. 2011;56(9): 2688-2695.
51. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99(9):1807-1814.
52. Lu CL, Chang FY, Chen CY, Luo JC, Lee SD. Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2006;24(2):429-438.
53. Kubo M, Fujiwara Y, Shiba M, et al. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterol Motil. 2011;23(3):249-254.
54. Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol. 2006;41(6):562-568.
55. Soares RL, Figueiredo HN, Santos JM, Oliveira RF, Godoy RL, Mendonca FA. Discrepancies between the responses to skin prick test to food and respiratory antigens in two subtypes of patients with irritable bowel syndrome. World J Gastroenterol. 2008;14(19): 3044-3048.
56. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res. 2008; 64(6):573-582.
57. Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24(10):895-913.
58. Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63(3):188-194.
59. Costedio MM, Coates MD, Brooks EM, et al. Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol. 2010;105(5):1173-1180.
60. Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53(6):829-837.
61. Dorn SD, Morris CB, Hu Y, et al. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol. 2009;43(3):214-220.
62. Ersryd A, Posserud I, Abrahamsson H, Simrén M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther. 2007;26(6):953-961.
63. Kilciler G, Sancaktutar AA, Avci A, Kilciler M, Kaya E, Dayanc M. Chronic constipation: facilitator factor for development of varicocele. World J Gastroenterol. 2011;17(21):2641-2645.
64. Mulak A, Paradowski L. Anorectal function and dyssynergic defecation in different subgroups of patients with irritable bowel syndrome. Int J Colorectal Dis. 2010;25(8):1011-1016.
65. Agrawal A, Houghton LA, Lea R, Morris J, Reilly B, Whorwell PJ. Bloating and distention in irritable bowel syndrome: the role of visceral sensation. Gastroenterology. 2008;134(7):1882-1889.
66. Basaranoglu M, Celebi S, Ataseven H, Rahman S, Deveci SE, Acik Y Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community. Digestion. 2008;77(1):10-15.
67. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007;26(11-12): 1521-1528.
68. Gupta D, Ghoshal UC, Misra A, Misra A, Choudhuri G, Singh K. Lactose intolerance in patients with irritable bowel syndrome from northern India: a case-control study. J Gastroenterol Hepatol. 2007; 22(12):2261-2265.
69. Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Aliment Pharmacol Ther. 2007;25(6):681-692.
70. Turgut AT, Ozden E, Koşar P, Koşar U, Cakal B, Karabulut A. Chronic constipation as a causative factor for development of varicocele in men: a prospective ultrasonographic study. J Ultrasound Med. 2007;26(1):5-10.
71. Guo XF, Ke MY, Wang ZF, Fang XC, Wu B, Tu YP Categorization of dysmotility in patients with chronic constipation and its significance for management. Chin J Dig Dis. 2004;5(3):98-102.
72. Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psychological enquiry. Eur J Gastroenterol Hepatol. 2001;13(1):39-44.
73. MATLAB [computer program]. Version 7.10.499 (R2010a). Plug-in Grabit. Natick, MA: The MathWorks, Inc. 2010. http://www.mathworks. com/matlabcentral/fileexchange/7173-grabit. Accessed April 25, 2012.